neuro

SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- neuro42, Inc. (“neuro42” or the “Company”), a medical technology company leading the next evolution of MRI and robotics, today announced…

<!-- Name:DistributionId Value:8842535 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

People with neurologic post-COVID sequelae showed immunologic imprinting from other common…

<!-- Name:DistributionId Value:8797122 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8797372 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8797372 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

People who had chronic pain at multiple body sites had an increased risk of dementia and…

SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…

An editorial by The Lancet aimed to balance hype and hope about the investigational…

SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and…